Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management challenges for chronic dysimmune neuropathies during the COVID‐19 pandemic
Yusuf A. Rajabally, H. Stephan Goedee, Shahram Attarian, et al.
Muscle & Nerve (2020) Vol. 62, Iss. 1, pp. 34-40
Open Access | Times Cited: 21

Showing 21 citing articles:

Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019
Adeel Zubair, Lindsay McAlpine, Tova Gardin, et al.
JAMA Neurology (2020) Vol. 77, Iss. 8, pp. 1018-1018
Open Access | Times Cited: 885
Significant reduction of physical activity in patients with neuromuscular disease during COVID-19 pandemic: the long-term consequences of quarantine
Vincenzo Di Stefano, Giuseppe Battaglia, Valerio Giustino, et al.
Journal of Neurology (2020) Vol. 268, Iss. 1, pp. 20-26
Open Access | Times Cited: 97
Neurological immunotherapy in the era of COVID-19 — looking for consensus in the literature
Catharina Korsukewitz, Stephen Reddel, Amit Bar‐Or, et al.
Nature Reviews Neurology (2020) Vol. 16, Iss. 9, pp. 493-505
Open Access | Times Cited: 65
Amyotrophic lateral sclerosis care and research in the United States during the COVID‐19 pandemic: Challenges and opportunities
Jinsy Andrews, James Berry, Robert H. Baloh, et al.
Muscle & Nerve (2020) Vol. 62, Iss. 2, pp. 182-186
Open Access | Times Cited: 51
A Scoping Review of Barriers and Facilitators Affecting the Lives of People With Disabilities During COVID-19
Samantha Croft, Sarah Fraser
Frontiers in Rehabilitation Sciences (2022) Vol. 2
Open Access | Times Cited: 29
Neuromuscular Diseases Care in the Era of COVID-19
B. Bertrán Recasens, M.Á. Rubio
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 39
COVID-19 and management of neuroimmunological disorders
Hans-Peter Hartung, Orhan Aktaş
Nature Reviews Neurology (2020) Vol. 16, Iss. 7, pp. 347-348
Open Access | Times Cited: 35
Complication of COVID-19: Mild Encephalopathy Syndrome with Reversible Splenial Lesion
Т. В. Матвеева, Rustem T. Gaifutdinov, D. Kamalova, et al.
Annals of Clinical and Experimental Neurology (2025) Vol. 18, Iss. 4, pp. 110-116
Open Access
Inflammatory neuropsychiatric disorders and COVID-19 neuroinflammation
Siu Wa Tang, Daiga M. Helmeste, Brian E. Leonard
Acta Neuropsychiatrica (2021) Vol. 33, Iss. 4, pp. 165-177
Open Access | Times Cited: 22
Physical Activity in Patients with Neuromuscular Disease Three Years after COVID-19, a Longitudinal Survey: The After-Effects of the Quarantine and the Benefits of a Return to a Healthier Life-Style
Ignazio Leale, Valerio Giustino, Paolo Trapani, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 1, pp. 265-265
Open Access | Times Cited: 3
Facing acute neuromuscular diseases during COVID-19 pandemic: focus on Guillain–Barré syndrome
Giuliana Galassi, Alessandro Marchioni
Acta Neurologica Belgica (2020) Vol. 120, Iss. 5, pp. 1067-1075
Open Access | Times Cited: 21
Neurological manifestations of severe acute respiratory syndrome coronavirus 2—a controversy ‘gone viral’
Moritz Förster, Vivien Weyers, Patrick Küry, et al.
Brain Communications (2020) Vol. 2, Iss. 2
Open Access | Times Cited: 7
Patient perceptions of outcome measures in chronic inflammatory demyelinating polyneuropathy: A study of the Inflammatory Rasch‐built Overall Disability Scale
Daniel K. White, Christina Englezou, Yusuf A. Rajabally
European Journal of Neurology (2021) Vol. 28, Iss. 8, pp. 2596-2602
Open Access | Times Cited: 7
Impact of COVID-19 pandemic in the activity of a Therapeutic Apheresis unit in Italy
Anna Colpo, Laura Astolfi, T. Tison, et al.
Transfusion and Apheresis Science (2020) Vol. 59, Iss. 6, pp. 102925-102925
Open Access | Times Cited: 6
Radiological profile of patients undergoing Chest X-ray and computed tomography scans during COVID-19 outbreak
Sohail Ahmed Khan, Murli Manohar, Maria Khan, et al.
Pakistan Journal of Medical Sciences (2021) Vol. 37, Iss. 5
Open Access | Times Cited: 6
Acute and chronic dysimmune polyneuropathies in the context of the COVID-19 pandemic: pathogenesis, features of the clinical picture, diagnosis and therapy (literature review)
A. Е. Khrulev, N. A. Shiyanova, С. Н. Сорокоумова, et al.
Neuromuscular Diseases (2021) Vol. 11, Iss. 2, pp. 17-27
Open Access | Times Cited: 3
Reduction of Infusion Time Using a 10% Intravenous Immunoglobulin Formulation With a 15-Minute Rate Escalation Protocol During Staffing Shortages Due to COVID-19
Barbara Prosser, Timothy P. Walton, Christine Miller
Journal of Infusion Nursing (2022) Vol. 45, Iss. 6, pp. 299-305
Open Access | Times Cited: 1
Current clinical management of CIDP with immunoglobulins in France: An expert opinion
Pascal Cintas, Françoise Bouhour, Cécile Cauquil, et al.
Revue Neurologique (2023) Vol. 179, Iss. 8, pp. 914-922
Open Access
Orientações Clínicas para a Abordagem de Doentes Neuromusculares Durante a Pandemia COVID-19
Isabel Conceição
Sinapse (2020) Vol. 20, Iss. 2, pp. 50-54
Closed Access
Efectos de la pandemia por Covid-19 sobre la calidad de vida de los pacientes con Esclerosis Lateral Amiotrófica
Sara Bermudo Fuenmayor, Pedro Jesús Serrano Castro, Pablo Quiroga, et al.
Enfermería Global (2021) Vol. 20, Iss. 3, pp. 581-600
Open Access
Page 1

Scroll to top